Successful clinical pregnancy in a case of severe Asherman syndrome: a case report
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20253759Keywords:
Asherman syndrome, Platelet-rich plasma, Granulocyte-colony stimulating factor, Hysteroscopic adhesiolysis, Endometrial regenerationAbstract
Asherman syndrome presents significant reproductive challenges due to intrauterine adhesions and impaired endometrial receptivity. We report a 36-year-old woman with primary infertility and recurrent adhesion formation who underwent serial hysteroscopic adhesiolysis. While endometrial thickness (EMT) is traditionally pivotal for predicting embryo implantation success, our findings indicate that endometrial receptivity extends beyond thickness alone. Factors such as endometrial morphology, type, and blood supply play crucial roles. Because previous attempts failed to yield viable embryos a donor ovum embryo transfer was planned, before which she received three subcutaneous injections of recombinant granulocyte-colony stimulating factor (G-CSF) followed by ultrasound-guided intrauterine platelet-rich plasma (PRP) infusions for improving endometrial quality, vascularity and ultimately receptivity, Following the sequential regenerative protocol with optimized hormonal support, she achieved a viable singleton pregnancy. This case demonstrates that hysteroscopic adhesiolysis followed by multiple (here minimum 3) systemic G-CSF followed by local PRP may synergistically enhance endometrial regeneration in severe Ashermans syndrome. Controlled studies are needed to evaluate the efficacy and safety of this combined approach and optimising the dosage and sessions of the same.
Metrics
References
Yu D, Wong YM, Cheong Y, Xia E, Li TC. Asherman syndrome–one century later. Fertil Steril. 2008;89(4):759-69. DOI: https://doi.org/10.1016/j.fertnstert.2008.02.096
March CM. Management of Asherman’s syndrome. Reprod Biomed Online. 2011;23(1):63-76. DOI: https://doi.org/10.1016/j.rbmo.2010.11.018
Korany S, Baradwan S, Badghish E, Miski NT, Alshahrani MS, Khadawardi K, et al. Value of intrauterine platelet-rich concentrates in patients with intrauterine adhesions after hysteroscopy: systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2022;271:63-70. DOI: https://doi.org/10.1016/j.ejogrb.2022.01.030
Lee D, Jo JD, Kim SK, Jee BC, Kim SH. Efficacy of intrauterine granulocyte colony-stimulating factor in improving endometrial thickness and reproductive outcomes in patients with thin endometrium following hysteroscopic adhesiolysis: randomized controlled trial. Hum Reprod. 2022;37(3):482-94.
Liu X, Qian C, Jiang X, Zhou Y, Feng X, Ding Y, et al. Efficacy of platelet-rich plasma in the treatment of thin endometrium: a meta-analysis of randomized controlled trials. BMC Pregnancy Childbirth. 2024;24(1):567. DOI: https://doi.org/10.1186/s12884-024-06741-3
Feng K, Zhu L, Luo Y, Ruan L, Li D, Li X, et al. Comparison of the efficacy of single vs. double autologous platelet-rich plasma intrauterine infusion on endometrial receptivity in thin endometrium patients: a prospective randomized controlled trial. Front Endocrinol (Lausanne). 2025;16:1609556. DOI: https://doi.org/10.3389/fendo.2025.1609556
Nayar KD, Arora S, Sanan S, Sachdeva M, Sethi A, Kant G, et al. Platelet-rich plasma therapy enhances endometrial receptivity in thin endometrium patients undergoing frozen embryo transfer cycles: results from a prospective cohort observational study. Eur J Obstet Gynecol Reprod Biol. 2025;315:114758. DOI: https://doi.org/10.1016/j.ejogrb.2025.114758
Nguyen TTN, Kwok YSS, Zhang C, Russell SJ, Librach CL. Unveiling the molecular mechanisms of human platelet lysate in enhancing endometrial receptivity. Hum Reprod. 2025;40(10):1957-71. DOI: https://doi.org/10.1093/humrep/deaf118